COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 627
[186] Macdonald RL, Weir BK. A review of hemoglobin and the
pathogenesis of cerebral vasospasm. Stroke. 1991;22(8):971-982.
[187] Shawkat H, Westwood MM, Mortimer A. Mannitol: a review of
its clinical uses. Contin Educ Anaesth Crit Care Pain.
2012;12(2):82-85.
[188] Pardridge WM. Drug transport across the blood-brain barrier.
J Cereb Blood Flow Metab. 2012;32(11):1959-1972.
[189] Geldenhuys WJ, Allen DD, Bloomquist JR. Novel models for
assessing blood-brain barrier drug permeation. Expert Opin Drug
Metab Toxicol. 2012;8(6):647-653.
[190] Janigro D, Bailey D, Lehmann S, et al. Peripheral blood and
salivary biomarkers of blood-brain barrier permeability and
neuronal damage: clinical and applied concepts. Front Neurol.
2020;11:577312.
[191] Obermeier B, Daneman R, Ransohoff RM. Development,
maintenance and disruption of the blood-brain barrier. Nat Med.
2013;19(12):1584-1596.
[192] Mayer F, Mayer N, Chinn L, Pinsonneault RL, Kroetz D, Bainton
RJ. Evolutionary conservation of vertebrate blood-brain barrier
chemoprotective mechanisms in Drosophila. J Neurosci.
2009;29(11):3538-3550.
[193] Köhler O, Benros ME, Nordentoft M, et al. Effect of
anti-inflammatory treatment on depression, depressive symptoms,
and adverse effects: a systematic review and meta-analysis of
randomized clinical trials. JAMA Psychiatry. 2014;71(12):1381-1391.
[194] Severance EG, Gressitt KL, Stallings CR, et al. Discordant
patterns of bacterial translocation markers and gut microbiome in
first-episode schizophrenia. Schizophr Bull. 2015;41(5):1068-1075.
627
